دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
پکیج دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
- :
قیمت : 1,500,000 تومان- قیمت ویژه : 750,000تومان
Underrepresentation of older patients in clinical trials in nephrology Open Access
doi : 10.1093/ckj/sfaf143
Inherited kidney disease and CAKUT are common causes of kidney failure: ERA Registry Figure of the month Open Access
doi : 10.1093/ckj/sfaf163
Clinical management of peripheral arterial disease in chronic kidney disease—a comprehensive review from the European Renal Association CKD-MBD Working Group Open Access
doi : 10.1093/ckj/sfaf089
Newer B-cell and plasma-cell targeted treatments for rituximab-resistant patients with membranous nephropathy Open Access
doi : 10.1093/ckj/sfaf088
Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases Open Access
doi : 10.1093/ckj/sfaf100
Malignancies and glomerulonephritis: when to suspect and when to screen? Open Access
doi : 10.1093/ckj/sfaf101
Targeting IL-6 in antibody-mediated kidney transplant rejection Open Access
doi : 10.1093/ckj/sfaf108
CKD-associated pruritus in haemodialysis: a road map for diagnosis and treatment Open Access
doi : 10.1093/ckj/sfaf096
Ten tips on how to manage kidney health in migrants and refugees Open Access
doi : 10.1093/ckj/sfaf132
Advanced chronic kidney disease coexisting with heart failure: navigating patients’ management Open Access
doi : 10.1093/ckj/sfaf128
Role of intrarenal complement production in kidney transplantation Open Access
doi : 10.1093/ckj/sfaf135
Long-term evaluation of the timing of corticosteroid therapy in an IgA nephropathy cohort Open Access
doi : 10.1093/ckj/sfaf076
Obinutuzumab is effective for the treatment of rituximab-refractory PLA2R-associated membranous nephropathy Open Access
doi : 10.1093/ckj/sfaf026
Causal effects of obesity on estimated glomerular filtration rate: a Mendelian randomization and image data analysis study Open Access
doi : 10.1093/ckj/sfaf116
Prophylactic anticoagulation in patients with nephrotic syndrome in the Cure Glomerulonephropathy (CureGN) cohort Open Access
doi : 10.1093/ckj/sfaf104
Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study Open Access
doi : 10.1093/ckj/sfaf125
Acute kidney injury does not explain sex differences in kidney replacement therapy initiation or death amongst individuals with chronic kidney disease reported to the UK Renal Registry Open Access
doi : 10.1093/ckj/sfaf105
Spatially resolved transcriptomic profiling for glomerular and tubulointerstitial gene expression in C3 glomerulopathy Open Access
doi : 10.1093/ckj/sfaf139
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease Open Access
doi : 10.1093/ckj/sfaf093
Urinary TWEAK reflects disease activity in ANCA-associated vasculitis Open Access
doi : 10.1093/ckj/sfaf086
Postoperative mid-to-long-term adverse event prediction model for patients receiving non-cardiac surgery: An extension of the Simple Postoperative AKI RisK (SPARK) model Open Access
doi : 10.1093/ckj/sfaf045
Development, Rasch analysis and validation of the kidney symptom burden questionnaire (KSB-Q) Open Access
doi : 10.1093/ckj/sfaf112
Fatigue across different chronic kidney disease populations: experiences and needs of patients Open Access
doi : 10.1093/ckj/sfaf118
The burden of hyperkalaemia in chronic kidney disease: a systematic literature review Open Access
doi : 10.1093/ckj/sfaf127
Incidence of cancer in people with CKD not requiring kidney replacement therapy: a systematic review and meta-analysis Open Access
doi : 10.1093/ckj/sfaf084
Impact of albuminuria screening in primary care on the detection and management of chronic kidney disease: findings from the ONDAAS study Open Access
doi : 10.1093/ckj/sfaf123
Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study Open Access
doi : 10.1093/ckj/sfaf103
Global, regional and national epidemiology of anemia attributable to chronic kidney disease, 1990–2021 Open Access
doi : 10.1093/ckj/sfaf138
Low serum free IL-18 is a novel potential marker for predicting infectious events in patients at dialysis initiation Open Access
doi : 10.1093/ckj/sfaf094
Extracorporeal myoglobin elimination using the adsorber CytoSorb or the high-flux HF80 dialyzer for patients with severe rhabdomyolysis: a comparative study Open Access
doi : 10.1093/ckj/sfaf071
Effects of super high-flux vitamin E–coated and medium cut-off dialyzers on uremic toxins removal and biocompatibility: the E-FLUX randomized controlled study Open Access
doi : 10.1093/ckj/sfaf106
High bicarbonate replacement fluid and time to pH normalization during continuous veno-venous hemofiltration with regional citrate anticoagulation: a retrospective single-center cohort study
doi : 10.1093/ckj/sfaf117
Implementation and evaluation of a smartphone-based application for continuous ambulatory peritoneal dialysis (CAPD) patients: a prospective feasibility cohort study and collaborative effort of patients and the peritoneal dialysis team Open Access
doi : 10.1093/ckj/sfaf102
Effectiveness of blood volume change–guided ultrafiltration control (BV-UFC) in hemodialysis: a crossover comparative study Open Access
doi : 10.1093/ckj/sfaf141
Association of dietary carbohydrate intake with risk of mortality in maintenance hemodialysis patients: a multicenter prospective cohort study Open Access
doi : 10.1093/ckj/sfaf124
Comparing hemodialysis and hemodiafiltration performance with and without hemoadsorption Open Access
doi : 10.1093/ckj/sfaf146
Self-limited, sodium-dependent osmotic diuresis causes polyuria after living donor kidney transplantation Open Access
doi : 10.1093/ckj/sfaf099
Risk of aspiration during general anaesthesia in patients on glucagon-like peptide-1 (GLP-1) receptor agonists: implications for patients on the kidney transplant waiting list Open Access
doi : 10.1093/ckj/sfaf110
Does nighttime hypertension predict long-term kidney outcomes in patients with IgA nephropathy?
doi : 10.1093/ckj/sfaf085
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor–associated membranous nephropathy Open Access
doi : 10.1093/ckj/sfaf113
The use of budesonide in IgA pediatric patients with recurrent macroscopic hematuria: a single-center real-life experience Open Access
doi : 10.1093/ckj/sfaf109
CD9 expression in minimal change disease and focal segmental glomerulosclerosis Open Access
doi : 10.1093/ckj/sfaf130
Correction to: The ERA Registry Annual Report 2022: Epidemiology of Kidney Replacement Therapy in Europe, with a focus on sex comparison Open Access
doi : 10.1093/ckj/sfaf107
Correction to: Clinical implications of mineralocorticoid receptor overactivation Open Access
doi : 10.1093/ckj/sfaf145
